Mode VC
Massachusetts

JDRF T1D Fund

JDRF T1D Fund, based in Massachusetts, backs Seed to Series B life sciences and healthtech startups, mostly following other investors, with a $250 million fund.

Website LinkedInPortfolioPitch pageTeam page
Entry stageSeed, Series A, Series B
Check sizen/a
Leads roundsMostly follows
FocusLife sciences, Healthtech
Latest fund$250 million+ AUM (2016)
Investing team7 peopleNo activity since Sep

Who you would pitch at JDRF T1D Fund

7 people on the investing team, 2 of them partners who can make the call. Partners are listed first.

Lucio Iannone, Ph.D.
Lucio Iannone, Ph.D.Managing DirectorHe previously led health investments at Leaps by Bayer and now serves as Managing Director at the T1D Fund.
Sylvia Tobé, Ph.D.
Sylvia Tobé, Ph.D.Managing DirectorShe has held roles at Omega Funds and Ra Pharmaceuticals, and currently serves on multiple boards.
Daniel Flicker, Ph.D.
Daniel Flicker, Ph.D.PrincipalHe previously worked at Novo Holdings, Chardan, and L.E.K.
Morgan Janes, Ph.D.
Morgan Janes, Ph.D.AssociateShe holds a Ph.D. from MIT and a B.S. from the University of Maryland, with experience in biotech and healthcare.
Peyman Hosseinchi
Peyman HosseinchiSenior AssociateHe previously worked at Raven Venture and RA Capital Management's TechAtlas division, and holds a PhD from the University of Chicago.
Valerie Su, Ph.D.
Valerie Su, Ph.D.AssociateShe previously worked at Sanofi as a Scientist, focusing on autoimmune disease drug discovery and external innovation.
Yash Malliwal
Yash MalliwalSenior AnalystHe previously worked as an Associate Consultant at Clarion Healthcare and holds a B.A. in Biology from Colby College.

Work here and something is wrong? Ask for a correction.

Check size not reported yet.

Bars: how many firms in the atlas report each band. Highlighted: this firm.

No recent activity since September 2026. Quiet does not mean closed.

Weekly count of activity updates. Activity is not a confirmed deal.

Notable investments

Aera TherapeuticsAdaxion TherapeuticsAspect BiosystemsAurimi TherapeuticsBigfoot BiomedicalBiolinqCapillary BiomedicalCOUR PharmaceuticalsDiasome PharmaceuticalsDiogenX
Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Alert me when JDRF T1D Fund is active

One email when this firm shows new activity. Nothing else.

Firms like JDRF T1D Fund

The Engine$250K to $10M · active Sep 22
Polaris Partners$500K to $10M
Blindspot VenturesCheck size not reported
Broadview VenturesCheck size not reported
Double Point VenturesCheck size not reported
F-Prime Capital$1M to $30M+

On these lists

Seed life sciences investors in Massachusetts27Seed healthtech investors in Massachusetts25Series A healthtech investors in Massachusetts24Series A life sciences investors in Massachusetts22Series B healthtech investors in Massachusetts11Series B life sciences investors in Massachusetts11Seed investors in United States2836Series A investors in United States1790

Questions

What stage does JDRF T1D Fund invest in?

JDRF T1D Fund reports entry at seed, series a, series b.

How much does JDRF T1D Fund invest?

JDRF T1D Fund has not reported a check size.

Does JDRF T1D Fund lead rounds?

JDRF T1D Fund mostly follows other investors.

Who are the partners at JDRF T1D Fund?

Lucio Iannone, Ph.D. (Managing Director), Sylvia Tobé, Ph.D. (Managing Director).

Is JDRF T1D Fund active right now?

No recent activity since September 2026.

Work at JDRF T1D Fund? Claim or correct this profile.